- Home
- SRZN vs XCBE Comparison
SRZN vs XCBE Comparison
Compare SRZN & XCBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$30.00
Company Overview
Basic Information| Metric | SRZN | XCBE |
|---|---|---|
| Founded | 2015 | 2025 |
| Country | United States | United States |
| Employees | 59 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.6M | 279.3M |
| IPO Year | 2020 | 2025 |
Fundamental Metrics
Financial Performance| Metric | SRZN | XCBE |
|---|---|---|
| Price | $30.00 | $10.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $48.40 | N/A |
| AVG Volume (30 Days) | ★ 644.8K | 32.4K |
| Earning Date | 11-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,477,000.00 | N/A |
| Revenue This Year | $208.89 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.39 | $9.75 |
| 52 Week High | $37.83 | $10.03 |
Technical Indicators
Market Signals| Indicator | SRZN | XCBE |
|---|---|---|
| Relative Strength Index (RSI) | 66.56 | 75.59 |
| Support Level | $23.55 | $9.88 |
| Resistance Level | $33.96 | N/A |
| Average True Range (ATR) | 2.29 | 0.00 |
| MACD | 1.63 | 0.00 |
| Stochastic Oscillator | 68.93 | 100.00 |
Price Performance
Historical Comparison SRZN
XCBE
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
About XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares
X3 Acquisition Corp Ltd is a blank check company.